Zobrazeno 1 - 10
of 423
pro vyhledávání: '"Chandrasekhar, Bal"'
Autor:
Rashi Goel, Swayamjeet Satapathy, Kunal Ramesh Chandekar, Sanjana Ballal, Shipra Agarwal, Suryanarayan S. V. Deo, Madhavi Tripathi, Chandrasekhar Bal
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionPlasma cell-free DNA (cfDNA) estimation offers a non-invasive method to potentially diagnose, monitor, and prognosticate patients with malignancy. This prospective study aimed to assess plasma cfDNA levels in patients with differentiated
Externí odkaz:
https://doaj.org/article/8d91b68108194188bbd42111fd71abc9
Autor:
Rahul Viswanathan, Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Parvind Sheokand, Swayamjeet Satapathy, Madhavi Tripathi, Shipra Agarwal, Euy Sung Moon, Chandrasekhar Bal
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 275 (2024)
Neuroendocrine tumors (NETs) are slow-growing tumors that express high levels of somatostatin receptors (SSTRs). Recent studies have shown the superiority of radiolabeled SSTR antagonists in theranostics compared to agonists. In this prospective stud
Externí odkaz:
https://doaj.org/article/fa1451c9d0304faeacd69e299083da0f
Autor:
Sivasankar Kanankulam Velliangiri, Sanjana Ballal, Madhav Prasad Yadhav, Madhavi Tripathi, Swayamjeet Satapathy, Chandrasekhar Bal
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294343 (2023)
ObjectiveSkeletal metastases in differentiated thyroid cancer (DTC) patients are associated with poor prognosis. The objective was to determine the maximum I-131 cumulative activity that could be safely administered without compromising efficacy. The
Externí odkaz:
https://doaj.org/article/7f779b097d6f4d009f80488cf991821a
Autor:
Biswamohan Mishra, Ankit Sachan, Chandrasekhar Bal, Achal K Srivastava, Amlesh Seth, Anubhav Narwal, Mehar C Sharma, Seema Kaushal, Anoop Saraya, Awadh K Pandit
Publikováno v:
Annals of Indian Academy of Neurology, Vol 25, Iss 6, Pp 1248-1250 (2022)
Externí odkaz:
https://doaj.org/article/2d3d29ac440a4b43979f8a4870fb6934
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Radioiodine-refractory differentiated thyroid cancer (RAIR-DTC), though uncommon, presents a considerable therapeutic challenge with poor long-term outcomes. Currently, tyrosine kinase inhibitors are the mainstay of treatment for advanced RAIR-DTC pa
Externí odkaz:
https://doaj.org/article/5037ba9e857842c6980fa31c821787bd
Autor:
Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Nicky Wakade, Shobhana Raju, Parvind Sheokand, Prashant Mishra, Euy Sung Moon, Madhavi Tripathi, Marcel Martin, Chandrasekhar Bal
Publikováno v:
Pharmaceuticals, Vol 16, Iss 4, p 521 (2023)
This study aimed to compare the diagnostic performance of [68Ga]Ga-DOTA.SA.FAPi with that of [18F]F-FDG PET/CT in detecting primary and metastatic lesions of breast cancer. [18F]F-FDG and [68Ga]Ga-DOTA.SA.FAPi PET/CT scans of histologically proven br
Externí odkaz:
https://doaj.org/article/859dc10bbab44138b3eb8ab05751a9e8
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract Background [177Lu]Lu-DOTA-ZOL has shown promising results from the dosimetry and preclinical aspects, but data on its role in the clinical efficacy are limited. The objective of this study is to evaluate the efficacy and safety of [177Lu]Lu-
Externí odkaz:
https://doaj.org/article/f3c73abeaba1476fae4cd7f01051c4fe
Autor:
Berthold A. Nock, Panagiotis Kanellopoulos, Euy Sung Moon, Maritina Rouchota, George Loudos, Sanjana Ballal, Madhav P. Yadav, Chandrasekhar Bal, Prashant Mishra, Parvind Sheokand, Frank Roesch, Theodosia Maina
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 776 (2023)
Aiming to expand the application of the SST2R-antagonist LM4 (DPhe-c[DCys-4Pal-DAph(Cbm)-Lys-Thr-Cys]-DTyr-NH2) beyond [68Ga]Ga-DATA5m-LM4 PET/CT (DATA5m, (6-pentanoic acid)-6-(amino)methy-1,4-diazepinetriacetate), we now introduce AAZTA5-LM4 (AAZTA5
Externí odkaz:
https://doaj.org/article/2f0690fde7c64c7fa0a01549ebc2a9b7
Publikováno v:
EJNMMI Research, Vol 9, Iss 1, Pp 1-10 (2019)
Abstract Background The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is l
Externí odkaz:
https://doaj.org/article/a80261dd81b14281b272e3f4b0d856bd
Autor:
Naresh Kumar, Priyanka Gupta, Shamim Ahmed Shamim, Viju Chirayil, Suresh Subramanian, Madhava B. Mallia, Chandrasekhar Bal
Publikováno v:
World Journal of Nuclear Medicine. 22:114-123
Objective The incidence of inoperable hepatocellular carcinoma (HCC) with/without malignant portal vein thrombosis (PVT) is increasing in India for the last decade; thus, Bhabha Atomic Research Centre (BARC), Mumbai, India, developed diethydithiocarb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3da5709406273c7eea971ffa64d69f44
https://doi.org/10.1055/s-0043-1764306
https://doi.org/10.1055/s-0043-1764306